Login   |  Users Online: 356 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
Year : 2008  |  Volume : 29  |  Issue : 3  |  Page : 128-132

Effect of Shireeshadi Ghanavati in the Management of Tamaka Shwasa

1 M.D. (Ayu.), Department of Kayachikitsa, IPGT & RA, Gujarat Ayurved University, Jamnagar, India
2 Director, IPGT & RA, Gujarat Ayurved University, Jamnagar, India

Correspondence Address:
Shweta Agarwa
M.D. (Ayu.), Department of Kayachikitsa, IPGT & RA, Gujarat Ayurved University, Jamnagar
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Considering the high prevalence of the disease and the need to look for alternative medicine, a randomized open clinical trial on 29 subjects of Tamaka Shwasa (Bronchial Asthma), screened on the basis of clinical findings were allocated to two groups. Group A having 15 cases received the trial drug Shireeshadi Ghanavati (SGV) and 14 cases in Group B received Shwasa Kuthar Rasa (SKR) as a control drug. In SGV group, 13.33% of patients were observed with complete remission and 40% patients got marked improvement, 20% each were observed as improved as well as unchanged. The response was encouraging and left the scope for further study.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal